Extensive cerebral venous sinus thrombosis after romiplostim treatment for immune thrombocytopenia (ITP) despite severe thrombocytopenia

被引：12
|
作者：
Ho, P. [1 ]
Khan, S. [2 ]
Crompton, D. [2 ]
Hayes, L. [1 ]
机构：
[1] Northern Hosp, Dept Haematol, Melbourne, Vic, Australia
[2] Northern Hosp, Dept Neurol, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2015年 / 45卷 / 06期
关键词：
THROMBOEMBOLISM; THROMBOPOIETIN; RISK;
D O I：
10.1111/imj.12765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [41] Clinical Conundrum: Return to High Altitude After Cerebral Venous Sinus Thrombosis
    Luks, Andrew M.
    DeLoughery, Thomas G.
    Gertsch, Jeffrey H.
    Stokes, Suzy
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2024, 25 (04) : 337 - 341
  • [42] Extensive cerebral venous sinus thrombosis following a dose increase in eltrombopag in a patient with idiopathic thrombocytopenic purpura
    Mulla, Christopher M.
    Rashidi, Armin
    Levitov, Alexander B.
    PLATELETS, 2014, 25 (02) : 144 - 146
  • [43] Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study
    van der Bruggen, Myrthe M.
    Kremers, Bram
    van Oerle, Rene
    van Oostenbrugge, Robert J.
    ten Cate, Hugo
    THROMBOSIS JOURNAL, 2021, 19 (01)
  • [44] Response loss and development of neutralizing antibodies during long-term treatment with romiplostim in patients with immune thrombocytopenia: a case series
    Carpenedo, Monica
    Cantoni, Silvia
    Coccini, Veronica
    Pogliani, Enrico Maria
    Cairoli, Roberto
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (01) : 101 - 103
  • [45] Anti-COVID-19 vaccines and rare cases of cerebral venous sinus thrombosis with thrombocytopenia: what about the pragmatic benefit/risk evaluation for still unvaccinated young women
    Lapi, Francesco
    Marconi, Ettore
    Mannucci, Pier Mannuccio
    Cricelli, Claudio
    EXPERT REVIEW OF VACCINES, 2022, 21 (04) : 431 - 433
  • [46] Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study
    Weber, E.
    Moulis, G.
    Mahevas, M.
    Guy, C.
    Lioger, B.
    Durieu, I.
    Hunault, M.
    Ramanantsoa, M.
    Royer, B.
    Default, A.
    Perault-Pochat, M. -C.
    Moachon, L.
    Bernard, N.
    Bardy, G.
    Jonville-Bera, A. -P.
    Geniaux, H.
    Godeau, B.
    Cathebra, P.
    REVUE DE MEDECINE INTERNE, 2017, 38 (03): : 167 - 175
  • [47] Direct oral anticoagulants in the treatment of cerebral venous sinus thrombosis: a single institution's experience
    Rusin, Gabriela
    Wypasek, Ewa
    Papuga-Szela, Elzbieta
    Zuk, Joanna
    Undas, Anetta
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2019, 53 (05) : 384 - 387
  • [48] Successful treatment of refractory secondary immune thrombocytopenia (antiphospholipid antibody syndrome-associated) with the combination of rituximab and romiplostim at the cost of severe bone pain: A case report and review of literature
    Yassa, Gizem
    Shakir, Abdur R.
    Jagarlamudi, Kuppuswamy
    Yassa, Ahmet E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (01) : 253 - 257
  • [49] Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis
    Zhang, Jiaxing
    Liang, Yi
    Ai, Yuan
    Li, Xiaosi
    Xie, Juan
    Li, Youping
    Zheng, Wenyi
    He, Rui
    PLOS ONE, 2018, 13 (06):
  • [50] The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP)
    Basciano, Paul A.
    Bussel, James
    Hafeez, Zeeshan
    Christos, Paul J.
    Giannakakou, Paraskevi
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (02) : 237 - 243
12345